We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $5.12B
1-Year Est. Return 314.02%
This Fund
S&P 500
This Quarter Est. Return
-14.51%
1 Year Est. Return
+314.02%
3 Year Est. Return
+1,498.66%
5 Year Est. Return
+2,457.67%
10 Year Est. Return
+48,821.41%
AUM
$1.25B
AUM Growth
-$409M
Cap. Flow
-$35.9M
Cap. Flow %
-2.87%
Top 10 Hldgs %
50.14%
Holding
212
New
40
Increased
31
Reduced
43
Closed
54

Top Buys

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$43.5M
2
RGNX icon
Regenxbio
RGNX
+$19.9M
3
ARAV
Aravive, Inc. Common Stock
ARAV
+$15.6M
4
ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
+$14.2M
5
LJPC
La Jolla Pharmaceutical Company
LJPC
+$12.7M

Top Sells

Rank Stock Value
1
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$19M
2
AGN
Allergan plc
AGN
+$18M
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$17.5M
4
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$17M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 77.95%
2 Consumer Discretionary 0.07%
3 Financials 0.04%
4 Energy 0.02%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOLD
1
DELISTED
Amicus Therapeutics
FOLD
$176M 14.03%
14,439,444
– –
NBIX icon
2
Neurocrine Biosciences
NBIX
$18.3B
$117M 9.35%
2,942,967
-341,500
-10% -$16.5M
SRPT icon
3
Sarepta Therapeutics
SRPT
$1.62B
$89.4M 7.14%
2,784,928
-24,600
-0.9% -$835K
TVTX icon
4
Travere Therapeutics
TVTX
$5.14B
$53.6M 4.28%
2,647,080
-173,795
-6% -$5.15M
TSRO
5
DELISTED
TESARO, Inc.
TSRO
$39.4M 3.14%
981,759
+146,400
+18% +$8M
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
$38.9M 3.1%
+921,800
New +$43.5M
DYAX
7
DELISTED
DYAX CORPORATION
DYAX
$31.4M 2.51%
1,646,315
-140,000
-8% -$3.34M
NVRO
8
DELISTED
NEVRO CORP.
NVRO
$28.1M 2.25%
606,811
-192,148
-24% -$9.31M
GWPH
9
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$27.4M 2.19%
+300,000
New +$33.4M
PTCT icon
10
PUT
PTC Therapeutics
PTCT
$6.21B
$26.8M 2.14%
+1,005,000
New +$43M
ARAV
11
DELISTED
Aravive, Inc. Common Stock
ARAV
$26.7M 2.13%
386,326
+166,093
+75% +$15.6M
IWM icon
12
PUT
iShares Russell 2000 ETF
IWM
$79.5B
$21.8M 1.74%
+200,000
New +$23.7M
XNCR icon
13
Xencor
XNCR
$1.44B
$21.5M 1.71%
1,754,784
-130,000
-7% -$2.54M
TLPH icon
14
Talphera
TLPH
$67.5M
$19.1M 1.53%
313,203
-15,500
-5% -$1.27M
RLYP
15
DELISTED
RELYPSA INC COM
RLYP
$18.3M 1.46%
987,942
-151,200
-13% -$4.15M
LJPC
16
DELISTED
La Jolla Pharmaceutical Company
LJPC
$18.2M 1.45%
654,515
+401,600
+159% +$12.7M
RGNX icon
17
Regenxbio
RGNX
$617M
$17.2M 1.37%
+779,213
New +$19.9M
XBI icon
18
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
$17.1M 1.37%
275,000
-175,000
-39% -$13.8M
IOVA icon
19
Iovance Biotherapeutics
IOVA
$2.04B
$17M 1.36%
2,955,456
+195,863
+7% +$1.53M
RXDX
20
DELISTED
Ignyta, Inc.
RXDX
$17M 1.35%
1,931,600
-36,000
-2% -$516K
CEMP
21
DELISTED
Cempra, Inc.
CEMP
$16.2M 1.3%
582,500
+10,000
+2% +$371K
PFNX
22
DELISTED
Pfenex Inc.
PFNX
$14.6M 1.16%
971,043
-39,834
-4% -$809K
QURE icon
23
uniQure
QURE
$2.74B
$14.1M 1.13%
690,269
+40,000
+6% +$1.05M
SSO icon
24
PUT
ProShares Ultra S&P500
SSO
$7.62B
$11.1M 0.89%
1,600,000
+1,200,000
+300% +$9.36M
SNDA icon
25
Sonida Senior Living
SNDA
$1.98B
$11.1M 0.89%
36,907
-5,793
-14% -$1.91M
1
2 3 4 5

Similar funds

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return

Perceptive Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Perceptive Advisors held 212 positions worth $1.25B, down 25% from $1.66B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors's Q3 2015 filing shows 40 new, 31 increased, 43 reduced and 54 closed positions. Its largest new stake was Global Blood Therapeutics, Inc.: 921,800 shares worth $38.9M. The largest sale was ZS PHARMA INC COMS TK (DE), an estimated $19M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 77% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Perceptive Advisors's largest Q3 2015 buy was Global Blood Therapeutics, Inc.: 921,800 shares worth $38.9M.
  • Perceptive Advisors added most to Aravive, Inc. Common Stock in Q3 2015, an estimated $15.6M increase.
  • Perceptive Advisors's biggest Q3 2015 reduction was ANI Pharmaceuticals, cutting an estimated $17.5M.
  • Perceptive Advisors fully exited ZS PHARMA INC COMS TK (DE) in Q3 2015, selling an estimated $19M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.25B portfolio in Q3 2015.
  • Perceptive Advisors opened 40 new positions and closed 54 in Q3 2015.
  • Perceptive Advisors's portfolio value fell 25% quarter-over-quarter to $1.25B.

Based on Perceptive Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.